Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

Gatta, 2014, Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5—a population-based study, Lancet Oncol, 15, 35, 10.1016/S1470-2045(13)70548-5 Robison, 2014, Survivors of childhood and adolescent cancer: life-long risks and responsibilities, Nat Rev Cancer, 14, 61, 10.1038/nrc3634 Poplack, 2014, Childhood cancer survivor care: development of the Passport for Care, Nat Rev Clin Oncol, 11, 740, 10.1038/nrclinonc.2014.175 Kremer, 2002, Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review, Ann Oncol, 13, 819, 10.1093/annonc/mdf167 Travis, 2006, The epidemiology of second primary cancers, Cancer Epidemiol Biomarkers Prev, 15, 2020, 10.1158/1055-9965.EPI-06-0414 Oeffinger, 2004, Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors, CA Cancer J Clin, 54, 208, 10.3322/canjclin.54.4.208 Oeffinger, 2006, Chronic health conditions in adult survivors of childhood cancer, N Engl J Med, 355, 1572, 10.1056/NEJMsa060185 Armstrong, 2014, Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study, J Clin Oncol, 32, 1218, 10.1200/JCO.2013.51.1055 Kang, 2013, Bone mineral density deficits in childhood cancer survivors: pathophysiology, prevalence, screening, and management, Korean J Pediatr, 56, 60, 10.3345/kjp.2013.56.2.60 Chemaitilly, 2010, Endocrine complications in longterm survivors of childhood cancers, Endocr Relat Cancer, 17, 141, 10.1677/ERC-10-0002 Wilson, 2013, Bone mineral density deficits and fractures in survivors of childhood cancer, Curr Osteoporos Rep, 11, 329, 10.1007/s11914-013-0165-0 Dickerman, 2007, The late effects of childhood cancer therapy, Pediatrics, 119, 554, 10.1542/peds.2006-2826 Pfeilschifter, 2000, Osteoporosis due to cancer treatment: pathogenesis and management, J Clin Oncol, 18, 1570, 10.1200/JCO.2000.18.7.1570 van der Sluis, 2000, Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood, Med Pediatr Oncol, 35, 415, 10.1002/1096-911X(20001001)35:4<415::AID-MPO4>3.0.CO;2-9 Choi, 2013, Factors related to decreased bone mineral density in childhood cancer survivors, J Korean Med Sci, 28, 1632, 10.3346/jkms.2013.28.11.1632 Gurney, 2014, Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study, Pediatr Blood Cancer, 61, 1270, 10.1002/pbc.25010 Makitie, 2013, Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study, Eur J Endocrinol, 168, 281, 10.1530/EJE-12-0702 Joyce, 2011, Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemia, Arch Phys Med Rehabil, 92, 873, 10.1016/j.apmr.2010.12.039 Marcucci, 2015, Rare causes of osteoporosis, Clin Cases Miner Bone Metab, 12, 151 Atkins, 2004, Grading quality of evidence and strength of recommendations, BMJ, 328, 1490, 10.1136/bmj.328.7454.1490 Rizzoli, 2010, Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly, Bone, 46, 294, 10.1016/j.bone.2009.10.005 Theintz, 1992, Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects, J Clin Endocrinol Metab, 75, 1060 Weaver, 2016, The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations, Osteoporos Int, 27, 1281, 10.1007/s00198-015-3440-3 Rizzoli, 1999, Determinants of peak bone mass and mechanisms of bone loss, Osteoporos Int, 9, S17, 10.1007/PL00004155 Muszynska-Roslan, 2014, Bone mineral density in pediatric survivors of Hodgkin and non-Hodgkin lymphomas, Adv Med Sci, 59, 200, 10.1016/j.advms.2014.02.004 Jackowski, 2009, Peak lean tissue mass accrual precedes changes in bone strength indices at the proximal femur during the pubertal growth spurt, Bone, 44, 1186, 10.1016/j.bone.2009.02.008 Gafni, 2004, Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA), J Pediatr, 144, 253, 10.1016/j.jpeds.2003.08.054 Ferrari, 2012, Osteoporosis in young adults: pathophysiology, diagnosis, and management, Osteoporos Int, 23, 2735, 10.1007/s00198-012-2030-x Crabtree, 2014, Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions, J Clin Densitom, 17, 225, 10.1016/j.jocd.2014.01.003 Bianchi, 2014, Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions, J Clin Densitom, 17, 281, 10.1016/j.jocd.2014.01.005 Zemel, 2009, Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery/Delphi dual-energy X-ray absorptiometry, J Clin Densitom, 12, 207, 10.1016/j.jocd.2009.01.005 Wasilewski-Masker, 2008, Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature, Pediatrics, 121, e705, 10.1542/peds.2007-1396 Almeida, 2017, Estrogens and androgens in skeletal physiology and pathophysiology, Physiol Rev, 97, 135, 10.1152/physrev.00033.2015 Chevalley, 2009, Deleterious effect of late menarche on distal tibia microstructure in healthy 20-year-old and premenopausal middle-aged women, J Bone Miner Res, 24, 144, 10.1359/jbmr.080815 Chevalley, 2008, Influence of age at menarche on forearm bone microstructure in healthy young women, J Clin Endocrinol Metab, 93, 2594, 10.1210/jc.2007-2644 Zemel, 2011, Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study, J Clin Endocrinol Metab, 96, 3160, 10.1210/jc.2011-1111 Karasik, 2008, Contribution of gender-specific genetic factors to osteoporosis risk, Ann Hum Genet, 72, 696, 10.1111/j.1469-1809.2008.00447.x Seeman, 2006, Bone quality—the material and structural basis of bone strength and fragility, N Engl J Med, 354, 2250, 10.1056/NEJMra053077 Vasikaran, 2011, Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards, Osteoporos Int, 22, 391, 10.1007/s00198-010-1501-1 Atkinson, 2008, Vitamin D status and bone biomarkers in childhood cancer, Pediatr Blood Cancer, 50, 479, 10.1002/pbc.21406 Hoorweg-Nijman, 1999, Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia, Clin Endocrinol (Oxf), 50, 237, 10.1046/j.1365-2265.1999.00654.x van Leeuwen, 2000, The effect of chemotherapy on the growing skeleton, Cancer Treat Rev, 26, 363, 10.1053/ctrv.2000.0180 Han, 2015, Poor bone health at the end of puberty in childhood cancer survivors, Pediatr Blood Cancer, 62, 1838, 10.1002/pbc.25581 Tillmann, 2002, Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia, J Bone Miner Res, 17, 1073, 10.1359/jbmr.2002.17.6.1073 Arikoski, 1999, Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study, J Clin Endocrinol Metab, 84, 3174, 10.1210/jcem.84.9.5968 Rohani, 2017, Bone mineral density in survivors of childhood acute lymphoblastic leukemia, Asian Pac J Cancer Prev, 18, 535 Högler, 2007, Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database, Pediatr Blood Cancer, 48, 21, 10.1002/pbc.20701 Alos, 2012, High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy, JCO, 30, 2760, 10.1200/JCO.2011.40.4830 Halton, 2009, Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program, J Bone Miner Res, 24, 1326, 10.1359/jbmr.090202 Rayar, 2012, Predictors of bony morbidity in children with acute lymphoblastic leukemia, Pediatr Blood Cancer, 59, 77, 10.1002/pbc.24040 Mostoufi-Moab, 2012, Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation, J Clin Endocrinol Metab, 97, 3584, 10.1210/jc.2012-2393 Nysom, 2000, Bone mass after allogeneic BMT for childhood leukaemia or lymphoma, Bone Marrow Transplant, 25, 191, 10.1038/sj.bmt.1702131 Luetke, 2014, Osteosarcoma treatment—where do we stand? A state of the art review, Cancer Treat Rev, 40, 523, 10.1016/j.ctrv.2013.11.006 Holzer, 2003, Bone mineral density in long-term survivors of highly malignant osteosarcoma, J Bone Joint Surg Br, 85, 231, 10.1302/0301-620X.85B2.13257 Pirker-Frühauf, 2012, Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma, Clin Orthop Relat Res, 470, 2874, 10.1007/s11999-012-2448-7 Lim, 2013, Young age at diagnosis, male sex, and decreased lean mass are risk factors of osteoporosis in long-term survivors of osteosarcoma, J Pediatr Hematol Oncol, 35, 54, 10.1097/MPH.0b013e318275193b Yaw, 1999, Pediatric bone tumors, Semin Surg Oncol, 16, 173, 10.1002/(SICI)1098-2388(199903)16:2<173::AID-SSU8>3.0.CO;2-G Hobusch, 2016, Do patients after chondrosarcoma treatment have age-appropriate bone mineral density in the long term?, Clin Orthop Relat Res, 474, 1508, 10.1007/s11999-016-4741-3 Pietila, 2006, Bone mineral density is reduced in brain tumour patients treated in childhood, Acta Paediatr, 95, 1291, 10.1080/08035250600586484 Fletcher, 1997, Effects of pediatric cancer therapy on the musculoskeletal system, Pediatr Radiol, 27, 623, 10.1007/s002470050201 Utriainen, 2017, Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue, Bone Marrow Transplant, 52, 711, 10.1038/bmt.2016.345 Skinner, 2017, Lancet Oncol, 18, e75, 10.1016/S1470-2045(17)30026-8 Kantartzis, 2013, Menstrual suppression in the adolescent, J Pediatr Adolesc Gynecol, 26, 132, 10.1016/j.jpag.2012.08.007 Magon, 2011, Gonadotropin releasing hormone agonists: expanding vistas, Indian J Endocrinol Metab, 15, 261, 10.4103/2230-8210.85575 Tritos, 2016, Effects of growth hormone on bone, Prog Mol Biol Transl Sci, 138, 193, 10.1016/bs.pmbts.2015.10.008 Mazziotti, 2006, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy, J Bone Miner Res, 21, 520, 10.1359/jbmr.060112 Rizzoli, 2015, Glucocorticoid-induced osteoporosis: who to treat with what agent?, Nat Rev Rheumatol, 11, 98, 10.1038/nrrheum.2014.188 Mazziotti, 2006, Trends Endocrinol Metab, 17, 144, 10.1016/j.tem.2006.03.009 van der Sluis, 2008, Osteoporosis in children with cancer, Pediatr Blood Cancer, 50, 474, 10.1002/pbc.21407 Song, 2018, Caring for survivors of childhood cancer: it takes a village, Curr Opin Pediatr, 30, 864, 10.1097/MOP.0000000000000681 Armstrong, 2010, Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study, Radiat Res, 174, 840, 10.1667/RR1903.1 Sklar, 1995, Chronic neuroendocrinological sequelae of radiation therapy, Int J Radiat Oncol Biol Phys, 31, 1113, 10.1016/0360-3016(94)00427-M Warner, 1999, Relative osteopenia after treatment for acute lymphoblastic leukemia, Pediatr Res, 45, 544, 10.1203/00006450-199904010-00014 Vassilopoulou-Sellin, 1999, Osteopenia in young adult survivors of childhood cancer, Med Pediatr Oncol, 32, 272, 10.1002/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G Meacham, 2003, Endocrine late effects of childhood cancer therapy, Curr Probl Pediatr Adolesc Health Care, 33, 217, 10.1016/S1538-5442(03)00053-1 Kaste, 2004, Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation, Bone Marrow Transplant, 33, 435, 10.1038/sj.bmt.1704360 Markbreiter, 1989, The effect of radiation on the fracture repair process. A biomechanical evaluation of a closed fracture in a rat model, J Orthop Res, 7, 178, 10.1002/jor.1100070204 Nyaruba, 1998, Bone fragility induced by X-ray irradiation in relation to cortical bone-mineral content, Acta Radiol, 39, 43, 10.1080/02841859809172147 Fidler, 2015, Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study, Br J Cancer, 112, 1857, 10.1038/bjc.2015.159 Balis, 1997, General principles of chemotherapy, 215 Arikoski, 1999, Disturbance in bone turnover in children with a malignancy at completion of chemotherapy, Med Pediatr Oncol, 33, 455, 10.1002/(SICI)1096-911X(199911)33:5<455::AID-MPO4>3.0.CO;2-3 Davies, 2005, Skeletal morbidity in childhood acute lymphoblastic leukaemia, Clin Endocrinol (Oxf), 63, 1, 10.1111/j.1365-2265.2005.02263.x Hesseling, 1998, Bone mineral density in long-term survivors of childhood cancer, Int J Cancer Suppl, 11, 44, 10.1002/(SICI)1097-0215(1998)78:11+<44::AID-IJC13>3.0.CO;2-A Crofton, 1998, Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia, J Clin Endocrinol Metab, 83, 3121 Serafino, 1999, Induction of apoptotsis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?, Anticancer Res, 19, 1909 Neglia, 1993, Care and treatment of long-term survivors of childhood cancer, Cancer, 71, 3386, 10.1002/1097-0142(19930515)71:10+<3386::AID-CNCR2820711742>3.0.CO;2-7 Womer, 1996, Ifosfamide and paediatrics: should this marriage be saved?, Eur J Cancer, 32A, 1100, 10.1016/0959-8049(96)00153-0 Loebstein, 1999, Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children, J Clin Pharmacol, 39, 454, 10.1177/009127009903900504 Rossi, 1999, Development of ifosfamideinduced nephrotoxicity: prospective follow-up in 75 patients, Med Pediatr Oncol, 32, 177, 10.1002/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H Mattano, 2003, The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting, Pediatr Transplant, 7, 71, 10.1034/j.1399-3046.7.s3.11.x Children’s Oncology Group. Children’s Oncology Group—The World’s Childhood Cancer Experts: About Us [online]. 2014; http://www.childrensoncologygroup.org/index.php/about. 2003 2003 Landier, 2004, Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline, JCO, 22, 4979, 10.1200/JCO.2004.11.032 2009, Long-term follow-up care for pediatric cancer survivors, Pediatrics, 123, 906, 10.1542/peds.2008-3688 Choudhary, 2013, Prevalence of vitamin D insufficiency in survivors of childhood cancer, Pediatr Blood Cancer, 60, 1237, 10.1002/pbc.24403 Othman, 2002, Osteopenia in survivors of Wilms tumor, Int J Oncol, 20, 827 Marinovic, 2005, Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study, Pediatrics, 116, e102, 10.1542/peds.2004-1838 Alikasifoglu, 2005, Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments, Am J Hematol, 80, 113, 10.1002/ajh.20438 Bilariki, 2010, Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivors, Horm Res Paediatr, 74, 319, 10.1159/000313378 Winzenberg, 2006, Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials, BMJ, 333, 775., 10.1136/bmj.38950.561400.55 Winzenberg, 2006, Calcium supplementation for improving bone mineral density in children, Cochrane Database Syst Rev, 19 Weaver, 2016, Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation, Osteoporos Int, 27, 367, 10.1007/s00198-015-3386-5 Rønne, 2019, Bone mass development in childhood and its association with physical activity and vitamin D levels. The CHAMPS-Study DK, Calcif Tissue Int, 104, 1, 10.1007/s00223-018-0466-5 Neville, 2015, The prevalence of Vitamin D deficiency is higher in adult survivors of childhood cancer, Clin Endocrinol (Oxf), 82, 657, 10.1111/cen.12721 Modan-Moses, 2012, Vitamin D status in pediatric patients with a history of malignancy, Pediatr Res, 72, 620, 10.1038/pr.2012.131 Cohen, 2016, Nutritional interventions for survivors of childhood cancer, Cochrane Database Syst Rev, 22 Pludowski, 2018, Vitamin D supplementation guidelines, J Steroid Biochem Mol Biol, 175, 125, 10.1016/j.jsbmb.2017.01.021 Jarfelt, 2006, Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia, Eur J Endocrinol, 154, 303, 10.1530/eje.1.02092 Rueegg, 2017, A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767], BMC Cancer, 5, 822., 10.1186/s12885-017-3801-8 MM Hudson, WLandier, S.Bhatia Long-Term Follow-up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. In Children’s Oncology Group (ed.), Version 2.0; www.survivorshipguidelines.org (24 December 2007, date last accessed). Ward, 2018, Anabolic therapy for the treatment of osteoporosis in childhood, Curr Osteoporos Rep, 16, 269, 10.1007/s11914-018-0434-z Appelman-Dijkstra, 2014, Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study, Clin Endocrinol, 81, 727, 10.1111/cen.12493 Bhasin, 2010, Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 95, 2536, 10.1210/jc.2009-2354 Dohle, 2015 Dwyer, 2015, Hypogonadism in adolescence, Eur J Endocrinol, 173, R15, 10.1530/EJE-14-0947 Morales, 2015, Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline, CMAJ, 187, 1369, 10.1503/cmaj.150033 Seftel, 2015, Critical update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: a systematic analysis, Mayo Clin Proc, 90, 1104, 10.1016/j.mayocp.2015.06.002 Watson, 2014, Treatment of hypogonadism in males, Pediatr Endocrinol Rev, 11, 230 Biggin, 2017, Long-term bisphosphonate therapy in osteogenesis imperfecta, Curr Osteoporos Rep, 15, 412, 10.1007/s11914-017-0401-0 Barr, 2002, Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate, Med Pediatr Oncol, 39, 44, 10.1002/mpo.10057 Lethaby, 2007, Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience, J Pediatr Hematol Oncol, 29, 613, 10.1097/MPH.0b013e318142b7a1 Wiernikowski, 2005, Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study, J Oncol Pharm Pract, 11, 51, 10.1191/1078155205jp145oa Lee, 2013, Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma, Blood Res, 48, 99, 10.5045/br.2013.48.2.99 Lim, 2016, Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density, Ann Pediatr Endocrinol Metab, 21, 21, 10.6065/apem.2016.21.1.21 Kanis, 2019, Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women, Aging Clin Exp Res, 31, 15, 10.1007/s40520-018-1109-4 Tarantino, 2017, Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology, J Orthop Traumatol, 18, 3, 10.1007/s10195-017-0474-7 Shaw, 2005, Bisphosphonate treatment of bone disease, Arch Dis Child, 90, 494, 10.1136/adc.2003.036590 Khan, 2017, Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the International Task Force on ONJ, J Clin Densitom, 20, 8, 10.1016/j.jocd.2016.09.005 Boyce, 2017, Denosumab: an emerging therapy in pediatric bone disorders, Curr Osteoporos Rep, 15, 283, 10.1007/s11914-017-0380-1 Cummings, 2018, Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension, J Bone Miner Res, 33, 190, 10.1002/jbmr.3337 Tsourdi, 2017, Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS, Bone, 105, 11, 10.1016/j.bone.2017.08.003 Geczova, 2015, Avascular necrosis of bone in childhood cancer patients: a possible role of genetic susceptibility, Bratisl Lek Listy, 116, 289 Girard, 2013, Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood, Haematologica, 98, 1089, 10.3324/haematol.2012.081265 Li, 2014, Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents, Biol Blood Marrow Transplant, 20, 587, 10.1016/j.bbmt.2013.12.567 Campbell, 2009, Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation, Cancer, 115, 4127, 10.1002/cncr.24474 Kunstreich, 2016, Osteonecrosis in children with acute lymphoblastic leukemia, Haematologica, 101, 1295, 10.3324/haematol.2016.147595 Te Winkel, 2014, Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia, Haematologica, 99, 430, 10.3324/haematol.2013.095562 Kadan-Lottick, 2008, Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study, J Clin Oncol, 26, 3038, 10.1200/JCO.2007.14.9088 Haupt, 2018, The ‘Survivorship Passport’ for childhood cancer survivors, Eur J Cancer, 102, 69, 10.1016/j.ejca.2018.07.006 Kremer, 2013, A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group, Pediatr Blood Cancer, 60, 543, 10.1002/pbc.24445 Tonorezos, 2018, Models of care for survivors of childhood cancer from across the globe: advancing survivorship care in the next decade, J Clin Oncol, 36, 2223, 10.1200/JCO.2017.76.5180